GEOVAX LABS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
GEOVAX LABS, INC. (GOVX) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 177.63 thousand shares as of 2020-09-29, per its 10-K filed 2022-03-09.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2022-03-09
- 2020-09-29: Stock Issued During Period, Shares, Conversion of Convertible Securities 177.63K shares; Stock Issued During Period, Shares, Conversion of Convertible Securities as first filed 177.63K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities | Stock Issued During Period, Shares, Conversion of Convertible Securities as first filed |
|---|---|---|
| 2020-09-29 | 177.63K shares 10-K · filed 2022-03-09 | 177.63K shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |